Company Description
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally.
The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems.
It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands.
In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors.
The company was incorporated in 2006 and is headquartered in Redwood City, California.
| Country | United States |
| Founded | 2006 |
| IPO Date | Nov 6, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,215 |
| CEO | Kevin R. Thornal |
Contact Details
Address: 1800 Bridge Parkway Redwood City, California 94065 United States | |
| Phone | 650-251-0005 |
| Website | nevro.com |
Stock Details
| Ticker Symbol | NVRO |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001444380 |
| CUSIP Number | 64157F103 |
| ISIN Number | US64157F1030 |
| Employer ID | 56-2568057 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Roderick H. MacLeod | Senior Vice President and Chief Financial Officer |
| Kashif Rashid | Senior Vice President, General Counsel and Corporate Secretary |
| Kevin R. Thornal | President, Chief Executive Officer and Director |
| Richard B. Carter | Chief Accounting Officer |
| Christofer Christoforou | Senior Vice President of Technical Operations |
| Geeta Kaveti | Vice President and Chief Compliance and Privacy Officer |
| Jon R. Shear | Senior Vice President of Corporate Development |
| Meredith Vornholt | Vice President of Global Marketing |
| Shana D. Ross M.B.A. | Senior Vice President and Chief of Human Resources Officer |
| Dr. David Caraway M.D., Ph.D. | Senior Vice President and Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 12, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 12, 2024 | DEF 14A | Other definitive proxy statements |
| Feb 23, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 23, 2024 | 10-K | Annual Report |
| Feb 21, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Feb 21, 2024 | 8-K | Current Report |
| Feb 21, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |